menu
    • menu

    Company profile for Chongqing Pharmaceutical Research Institute Co Ltd

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Chongqing Pharmaceutical Research Institute Co., Ltd. (CPRI) is an R&D-based & client-oriented enterprise engaged in: Pharmaceutical R&D Early stage process development cGMP manufacturing of APIs & advanced intermediates Founded in 1950s, formerly known as the state-owned Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufacturing in China. In 2001, CP...
    Chongqing Pharmaceutical Research Institute Co., Ltd. (CPRI) is an R&D-based & client-oriented enterprise engaged in: Pharmaceutical R&D Early stage process development cGMP manufacturing of APIs & advanced intermediates Founded in 1950s, formerly known as the state-owned Chongqing Pharmaceutical Research Institute, CPRI was one of the pioneers involved in drug R&D and cGMP-compliant API manufacturing in China. In 2001, CPRI became a subsidiary of FOSUN Pharmaceutical (Group), Co, Ltd, which is a leading pharmaceutical company in China.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Chongqing Pharmaceutical Research Institute Co LtdChina Flag
    Country
    Country
    China
    Address
    Address
    Tushan 565, Nanan District Chongqing, 400061P.R.China
    Telephone
    Telephone
    86-23-62504026
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.cpri.com.cn/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/chongqing-pharmaceutical-research-institute-co-ltd-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chongqing Pharma Research Institute Co., Ltd on Health Canada Inspection List
    Chongqing Pharma Research Institute Co., Ltd on Health Canada Inspection List

    25 Mar 2017

    // HEALTH CANADA

    http://www.hc-sc.gc.ca/dhp-mps/pubs/compli-conform/tracker-suivi-eng.php

    HEALTH CANADA
    25 Mar 2017
    Share Share
    Chongqing Pharma Research Institute Receives FDA Warning letter
    Chongqing Pharma Research Institute Receives FDA Warning letter

    01 Mar 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/chongqing-pharma-research-institute-receives-fda-warning-letter-1488363786.pdf

    FDA
    01 Mar 2017
    Share Share
    Fosun-owned API maker Chongqing criticized by US FDA
    Fosun-owned API maker Chongqing criticized by US FDA

    01 Mar 2017

    // Gareth MacDonald+ IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Fosun-owned-API-maker-Chongqing-criticized-by-US-FDA

    Gareth MacDonald+ IN PHARMATECHNOLOGIST
    01 Mar 2017
    Share Share

    ABOUT THIS PAGE

    Contact Chongqing Pharmaceutical Research Institute Co Ltd and get a quotation

    Chongqing Pharmaceutical Research Institute Co Ltd is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find Pemetrexed Disodium bulk with JDMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Canagliflozin bulk with DMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Hydrotalcite Bp bulk with DMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Iron Sucrose bulk with DMF offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Abiraterone Acetate bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Amrinone bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Carfilzomib bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Find Pemetrexid disodium salt bulk offered by Chongqing Pharmaceutical Research Institute Co Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search